REAL News for RDs
Saturday, October 24, 2026 · UTC
Dietetics News
The Evidence

GLP-1 users advised to obtain dietitian referral for nutritional risks

Published guidance outlines documented deficiency risks for people taking the medication class.

Food is Medicine Writer
Share on X
Stands on 4 placed sources from 2 publishers.
Medical Xpress published guidance October 21 recommending GLP-1 users experiencing reduced appetite consult a doctor for referral to an accredited dietitian.[1] Approximately 500,000 Australians use GLP-1 medications for diabetes. Additional users take the drugs for obesity and weight-related conditions.[2] Documented nutritional risks from GLP-1 use include thiamine deficiency, metabolic acidosis, low magnesium and low blood sugar.[3] Guidance filed October 23 also advises people with IBS to consult a qualified dietitian before adjusting fiber intake.[4]
Proof4 sources · 2 publishers · signed
What this stands on
  1. The article recommends GLP-1 users experiencing reduced appetite consult a doctor for referral to an accredited dietitian. · Medical Xpress
  2. Approximately 500,000 Australians use GLP-1 medications for diabetes, with additional users taking them for obesity and weight-related conditions. · Medical Xpress
  3. Documented nutritional risks from GLP-1 use include thiamine deficiency, metabolic acidosis, low magnesium and low blood sugar. · Medical Xpress
  4. The article advises people with IBS to consult a qualified dietitian before adjusting fiber intake. · mindbodygreen
We could not place any of them by their address. None is an official body: that part stands on reporting, not on the underlying document or transcript.